Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Conversational Engagement as a Means to Delay Alzheimer's Disease Onset
Authors not listed
Oregon Health and Science University · 2012
Abstract
Past epidemiological studies have demonstrated that larger social networks, or more frequent social interactions, could have potential protective effects on the incidence of Alzheimer's Disease (AD). However, in those studies, indicators of social interactions were often broad, and included distinct elements that affected cognition and overall health. This project will examine whether conversation-based cognitive stimulation has positive effects on domain-specific cognitive functions among the elderly. Face-to-face communication will be conducted through the use of personal computers, webcams, and user-friendly simple interactive Internet programs to allow participants to have social engagement while staying at their home and also for the cost effective execution of the study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2012). Conversational Engagement as a Means to Delay Alzheimer's Disease Onset. <em>Oregon Health and Science University</em>. https://clinicaltrials.gov/study/NCT01571427
Vancouver
Anonymous. Conversational Engagement as a Means to Delay Alzheimer's Disease Onset. Oregon Health and Science University. 2012.
BibTeX
@misc{anon2012Conver,
title = {Conversational Engagement as a Means to Delay Alzheimer's Disease Onset},
author = {Anonymous},
journal = {Oregon Health and Science University},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The University of Texas Health Science Center at San Antonio 2015
Open access · US-GOV
Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
AbbVie 2015
Open access · US-GOV
A Study to Evaluate the Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of Multiple Doses of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment Due to Alzheimer's Disease
Posit Science Corporation 2004
Open access · US-GOV
Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease
Palo Alto Veterans Institute for Research 2013
Open access · US-GOV
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment
University of Kansas 2008
Open access · US-GOV
Effects of Intense Cognitive Training on Standardized Measures of Cognition in Those With Very Mild Alzheimer's Disease
University Hospital, Strasbourg, France 2013
Open access · US-GOV